Have you ever heard of a guy named Clay Siegall? How about a company named Seattle Genetics? Well, Clay Siegall is the head man in charge at one of the world’s most advanced cancer research facilities. Being the (CEO) as well as the President can be frustrating at times, but Dr. Siegall has the mental perseverance to keep pushing through. This guy is well accomplished with a (BS) in Zoology from The University of Maryland and a Ph.D in Genetics from George Washington University. Having such a heart of gold, Dr. Siegall has won numerous industry related award throughout the years and he’s the author of up to 70 publications.
His leadership role at Seattle Genetics has caused a surge in the company’s success over the years. The Bothell, Washington based company has been visited by Vice President Joe Biden for congratulatory purposes and Forbes Magazine ranked the company as one of the fastest growing companies in the U.S. in a 12 month span. Seattle Genetics specializes in cancer breakthrough therapies known as antibody drug conjugates. These advanced treatments are far better than medications of the past thanks to their life saving capabilities. ADCs can deliver a killing agent right into cancer cells without ever harmful and of the good cells within the body. Dr. Siegall has entered into multiple licensing deals with some of the biggest names like GlaxoSmithKline, Pfizer, AbbVie, and Genentech. As of today it’s top drug ADCETRIS is currently being sold in over 65 countries worldwide.
With the expanding of it’s drug pipeline, Seattle Genetics will be going on another hiring spree. The company already has over 800 employees/staff and with this expansion, 100 more individuals will be added to the roster. Dr. Clay Siegall has a great following on social media as well. The company’s social media is flooded with activity such as updates, followers, and business related news as well as future and present events. With Dr. Clay Siegall in charge, cancer has a one way ticket to extinction.